Korea University Anam Hospital hosts ‘2026 Mongolia Patients’ Night’ in Ulaanbaatar
Korea University Anam Hospital’s International Healthcare Center hosted the "2026 Mongolia Patients’ Night" on August 13 at the Holiday Inn in...
Search results for "cancer patient"
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche Group, for its next-generation...
Deciphering Ampullary Cancer: Korean Researchers Identify Aggressive Subtype of Rare Disease
Where the bile duct and pancreatic duct meet to drain digestive juices into the duodenum, a rare and elusive malignancy...
Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines
Samyang Biopharm announced on the 20th that nonclinical study results for its proprietary gene delivery platform,...
Preserving Form and Hope: Korean Surgeon Reaches 500th Robotic Breast Cancer Operation
Patients preparing for breast cancer surgery often ask a quiet question before entering the operating room.
Korean Surgeons Settle Decades-Long Debate Over Rectal Cancer Technique
Outside the operating room, a patient’s family waits anxiously. Although the rectal cancer surgery has concluded...
Yonsei Cancer Center Expands Carbon-Ion Therapy to Head and Neck Cancers, Sarcomas, and Recurrent Rectal Cancers
For patients facing cancers that are anatomically difficult to operate on or resistant to conventional radiation—as...
National University Hospitals Shift to Health Ministry After 21 Years to Lead Regional Care
Supervisory authority over South Korea’s national university and dental hospitals will officially transfer from the...
Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors
When a specific gene or protein is expressed at unusually high levels in diseased tissue, determining whether the...
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...